| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,259,821 |
|
|
|
Indirect Value
|
$148,965,006 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$150,224,827 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2010-11-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,275 |
1,519 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-10-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,500 |
169,444 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2007-10-29 |
4/A |
GD |
$0.00 |
$0 |
I/I |
5,550 |
149,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-11-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,600 |
6,794 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-03-12 |
4 |
D |
$44.04 |
$261,950 |
D/D |
(5,948) |
1,090,125 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-02-15 |
4 |
S |
$33.12 |
$212,166 |
I/I |
(6,400) |
800 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-02-05 |
4 |
OE |
$15.27 |
$99,955 |
D/D |
6,548 |
1,083,073 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$497,092 |
D/D |
(7,070) |
24,011 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
D |
$80.69 |
$570,559 |
D/D |
(7,071) |
28,995 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2011-03-15 |
4 |
D |
$39.79 |
$313,386 |
D/D |
(7,876) |
1,061,922 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,794 |
31,081 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,393 |
2,317,800 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,393 |
19,602 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2011-03-15 |
4/A |
D |
$39.79 |
$376,095 |
D/D |
(9,452) |
1,063,721 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-11-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
2,306,849 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
2,308,407 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,558 |
12,453 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,558 |
2,318,407 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-04 |
4 |
OE |
$6.53 |
$78,376 |
D/D |
12,000 |
202,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2010-03-08 |
4 |
D |
$47.01 |
$570,513 |
D/D |
(12,136) |
1,052,346 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-03-06 |
4 |
D |
$45.40 |
$568,544 |
D/D |
(12,523) |
2,159,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
1,075,733 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
1,096,073 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-02-13 |
4 |
OE |
$7.40 |
$99,969 |
D/D |
13,512 |
518,581 |
|
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2021-12-06 |
4 |
B |
$12.09 |
$173,492 |
D/D |
14,356 |
212,480 |
2.81 |
- |
|
193 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
